WEST CHESTER, Penn., July 29, 2025 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) – Johnson & Johnson MedTech, a global leader in orthopaedic technologies and solutions, today announced the launch of ...
Please provide your email address to receive an email when new articles are posted on . Lapidus bone-block fusion yielded a minor complication rate of 3% and a major complication rate of 6%. Patients ...
NEW YORK--(BUSINESS WIRE)--Voom™ Medical Devices, Inc. (“Voom”), a rapidly growing orthopedic medical device company with a primary focus on pioneering innovative solutions for minimally invasive ...
CAMP HILL, Pa.--(BUSINESS WIRE)--Forma Medical Inc., a leader in orthopedic Minimally Invasive Surgery (MIS) solutions, today announced the limited market release of OptimalTMT, an innovative MIS ...
Johnson & Johnson (NYSE:JNJ) is one of the top cheap pharmaceutical stocks to buy now. On July 29, Johnson & Johnson (NYSE:JNJ) MedTech announced the launch of the VIRTUGUIDE™ System, an AI-powered, ...
Bunions are among the most common foot problems, affecting nearly one-third of adults in the U.S. 4, yet traditional Lapidus surgery to treat the condition is often challenging. 5,6 The VIRTUGUIDE™ AI ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results